Breast Imaging

Women's health related to breast imaging, including mammography, breast MRI, ABUS, automated breast ultrasound, breast ultrasound, breast biopsy, PEM and positron emission mammography.

Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation, announced today that it has signed a definitive agreement to be acquired by Hologic, Inc., a global leader in women's health, for an enterprise value of approximately $795 million.  This includes a cash payment of approximately $714 million for Mobidiag’s equity, and net debt of approximately $81 million.
News | Women's Health
Mobidiag to be Acquired by Hologic for $795M

April 8, 2021 — Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular ...

Time April 08, 2021
arrow
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal
News | Artificial Intelligence
Artificial Intelligence Improves Accuracy of Breast Ultrasound Diagnoses

April 6, 2021 — In 2020, the International Agency for Research on Cancer of the World Health Organization stated that ...

Time April 06, 2021
arrow
 iCAD, Inc. announced that ProFound AI for 2D Mammography might notably reduce the risk of interval breast cancer, according to a retrospective analysis recently published in the Journal of Medical Screening. 
News | Breast Imaging
New Research Indicates ProFound AI May Reduce Interval Breast Cancer Rates

April 2, 2021 — iCAD, Inc. announced that ProFound AI for 2D Mammography might notably reduce the risk of interval ...

Time April 02, 2021
arrow
While the COVID-19 crisis is challenging, the pandemic is also giving researchers an opportunity to discover new approaches to saving lives. A study published in the JAMA Network Open on Thursday, March 25, 2021, recommends a new way for triaging mammogram patients during times of limited capacity, such as pandemic surges, when individuals may also experience anxiety about COVID-19.
News | Breast Imaging
Catching More Breast Cancers When Mammograms are Limited

April 1, 2021 — While the COVID-19 crisis is challenging, the pandemic is also giving researchers an opportunity to ...

Time April 01, 2021
arrow
In looking at the broader impact of the COVID-19 pandemic on health and wellbeing, public health experts are examining screening rates for cancer. A new study looking at U.S. mammography screening rates during the first five months of the pandemic found both a strong rebound in breast cancer screening rates and a concerning cumulative deficit in mammograms due to missed appointments, as well as uncovering disparities when looking at screening according to race
News | Breast Imaging
National Study Examines US Mammography Screening Rates During Epidemic

April 1, 2021 — In looking at the broader impact of the COVID-19 pandemic on health and wellbeing, public health experts ...

Time April 01, 2021
arrow
Videos | Breast Imaging
VIDEO: COVID Vaccine May Cause Enlarged Lymph Nodes on Mammograms

Constance "Connie" Lehman, M.D., Ph.D., chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation ...

Time March 26, 2021
arrow
iCad announced that ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) was cleared by the U.S. Food and Drug Administration (FDA).
News | Breast Imaging
FDA Clears for ProFound AI Version 3.0 for 3D Mammography

March 23, 2021 — iCad announced that ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) was cleared by the U ...

Time March 23, 2021
arrow
Detection of tumor-infiltrating lymphocytes (TILs) using explainable AI. The AI-technique is used to generate a heatmap showing TILs (red) and other tissues and cells (blue and green). Image courtesy of Klauschen/Charité
News | Artificial Intelligence
Making the Role of AI in Breast Cancer Explainable

March 22, 2021 — Researchers at Charité - Universitätsmedizin Berlin and TU Berlin as well as the University of Oslo ...

Time March 22, 2021
arrow
Left to right: Subtraction right mediolateral oblique (MLO) CEM was non-diagnostic because of artifact, potentially due to motion misregistration from extended exposure time; subtraction right MLO implant displaced CEM image shows 5.8 cm enhancing mass (arrow); contrast-enhanced MRI sagittal subtraction image shows concordant mass (arrow).
News | Breast Imaging
Contrast-Enhanced Mammography for Breast Cancer in Women With Augmented Breasts

March 18, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), contrast-enhanced mammography (CEM) showed ...

Time March 18, 2021
arrow
Attending the two most recent screening appointments before a breast cancer diagnosis protects against breast cancer death, according to a Queen Mary University of London study of over half a million Swedish women conducted over 24 years
News | Breast Imaging
Attending Consecutive Mammography Screens Protects Against Breast Cancer Death

March 12, 2021 — For women who had participated in both of their previous two screening examinations, the incidence of ...

Time March 12, 2021
arrow
Breast cancer is the most common fatal cancer in women. Early detection increases a woman's chances of recovery. Magnetic Resonance Imaging (MRI) is an accurate technique for detecting and classifying tumors in breast tissue.
News | MRI Breast
Simple MRI Measurement Could Avoid 30% of Breast Biopsies

March 9, 2021 — Breast cancer is the most common fatal cancer in women. Early detection increases a woman's chances of ...

Time March 09, 2021
arrow
A comparison of standard mammography imaging (left) in a woman with dense breasts and a breast MRI imaging study (right) showing a clearly defined cancer and is extremely hard to detect on the mammograms.
Feature | MRI Breast | By Dave Fornell, Editor
Use of Breast MRI Screening in Women With Dense Breasts

Dense breast tissue can hide cancers in mammograms in about half of women. Supplemental imaging is often needed to ...

Time March 04, 2021
arrow
Researchers said women who skip even one scheduled mammography screening before a breast cancer diagnosis face a significantly higher risk of dying from the cancer.
News | Mammography
Skipping Mammogram Increases Risk of Death from Breast Cancer

March 3, 2021 — Attendance at regular mammography screening substantially reduces the risk of dying from breast cancer ...

Time March 03, 2021
arrow
55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned. #COVIDvaccine #COVID19
News | Breast Imaging
COVID-19 Vaccination Axillary Adenopathy Detected During Breast Imaging

February 24, 2021 — An open-access article in ARRS’ American Journal of Roentgenology (AJR) describes the clinical and ...

Time February 24, 2021
arrow
Breast Cancer Index added to National Comprehensive Cancer Network guidelines to predict benefit from extended endocrine therapy
News | Women's Health
Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market

February 23, 2021 — Hologic, Inc. has completed its previously announced acquisition of molecular oncology leader ...

Time February 23, 2021
arrow
F-18 FES PET images of patients with ER+/PR+/HER2- invasive ductal carcinoma. Left panel: Progressive disease seen at the 8-week time-point in a patient on sequential therapy. Right panel: Stable disease through all 3 time-points, remaining on study therapy for 6.7 months until disease progression on combined vorinostat aromatase inhibitor therapy. Image created by Lanell M Peterson, Research Scientist, University of Washington Medical Oncology, Seattle WA.
News | Molecular Imaging
Molecular Imaging Determines Effectiveness of Novel Metastatic Breast Cancer Treatment

February 22, 2021 — Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2 ...

Time February 22, 2021
arrow
Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in
News | Breast Imaging
Advances in X-ray Imaging can Help Patients with Breast Cancer

February 22, 2021 — A new X-ray imaging scanner to help surgeons performing breast tumor removal surgery has been ...

Time February 22, 2021
arrow
Screening strategy based on baseline breast density at age 40 may be effective and cost-effective for reducing breast cancer mortality
News | Breast Density
Risk-based Breast Cancer Screening

February 10, 2021 — A mammography screening strategy based on a baseline breast density measure at age 40 may be the ...

Time February 10, 2021
arrow
Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8).
News | Breast Imaging
Breast Cancer Death Rates Stop Declining in Younger Women

February 10, 2021 — Breast cancer death rates have stopped declining for women in the U.S. younger than age 40, ending a ...

Time February 10, 2021
arrow
After acquiring the molecular breast imaging (MBI) assets from GE Healthcare and Dilon Technologies, Inc., SmartBreast Corporation (SmartBreast), a privately held company focused on breast cancer screening and diagnosis, announced today that it has formed a partnership with FoxSemicon Integrated Technologies, Inc. (FITI) to manufacture molecular breast imaging (MBI) systems.
News | Breast Imaging
SmartBreast Forms Molecular Breast Imaging Partnership with FITI

February 9, 2021 — After acquiring the molecular breast imaging (MBI) assets from GE Healthcare and Dilon Technologies ...

Time February 09, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now